home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Variants Associated with Hearing Loss in Children Receiving Chemotherapy Medication

  November, 19 2009 18:21
your information resource in human molecular genetics

An association between a chemotherapy-induced hearing loss and specific genetic variants has been identified, according to a new study published online in Nature Genetics. The study suggests that these genetic variants may be useful to identify individuals with increased risk of chemotherapy-induced hearing loss, which could help to manage treatment.

Cisplatin is a commonly used chemotherapy drug, although its side-effects include serious hearing loss in 10-25% of adults and 41-61% of children. In order to identify genetic variants that may be associated with increased risk of cisplatin-induced hearing loss, Colin Ross and colleagues analyzed 220 drug-metabolism genes from over 150 children receiving cisplatin chemotherapy. The scientists found that in these children, variants in the genes TPMT and COMT are significantly associated with cisplatin-induced hearing loss.

Further research is needed to determine whether these findings will be useful in guiding treatment options in a clinical setting.

Author contact:

Colin Ross (University of British Columbia, Vancouver, Canada)
E-mail: colinross1@gmail.com

Abstract available online.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.